We recently compiled a list of the 8 Hot Growth Stocks To Buy According to Hedge Funds. In this article, we are going to take ...

Axonics Modulation Technologies (AXNX) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.08 per share a year ...

Accelerate Diagnostics, Inc. today announced financial results for the third quarter ended September 30, 2024. "We are excited ...

IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — Axonics Modulation Technologies Inc. (AXNX) on Thursday reported a third-quarter loss of $21,000, after reporting a profit in the same period a year earlier ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Outset Medical (OM – Research Report), Pacira ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zimmer Biomet Holdings (ZBH – Research ...

Orange County’s fastest growing public companies are a diverse mix of real estate, biotech, software and hospitality ...

BSX's Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of gastrointestinal and pulmonary treatment options.

Here is how Applied Therapeutics Inc. (APLT) and Axonics Modulation Technologies (AXNX) have performed compared to their sector so far this year.

On Friday, Axonics Inc (AXNX) stock saw a decline, ending the day at $70.23 which represents a decrease of $-0.05 or -0.07% from the prior close of $70.28. The stock opened at $70.3 and touched a low ...